World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0004497996
Reproduction Date:

Title: Topotecan  
Author: World Heritage Encyclopedia
Language: English
Subject: List of chemotherapeutic agents, Camptothecin, Amrubicin, GlaxoSmithKline Pakistan, Allen & Hanburys
Collection: Lactams, Lactones, Pyranoindolizinoquinolines, Topoisomerase Inhibitors
Publisher: World Heritage Encyclopedia


Systematic (IUPAC) name
quinoline-3,14(4H,12H)-dione monohydrochloride
Clinical data
Trade names Hycamtin
Pregnancy cat.
Legal status
Routes Intravenous infusion, oral
Pharmacokinetic data
Bioavailability 31.4 % in humans [1][2]
Protein binding 35%
Metabolism Hepatic
Half-life 2-3 hours
Excretion Renal
CAS number  N 119413-54-6 (hydrochloride)
ATC code L01
ChemSpider  YesY
Chemical data
Formula C23H23N3O5 •HCl 
Mol. mass 457.9 g/mol

Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a water-soluble derivative of camptothecin. It is used in form of the hydrochloride to treat ovarian cancer and lung cancer, as well as other cancer types.

After GlaxoSmithKline received final FDA approval for Hycamtin Capsules on October 15, 2007, topotecan is the first topoisomerase I inhibitor for oral use.


  • Indications (approved uses) 1
  • Experimental use 2
  • Mode of action 3
  • Side effects 4
  • Generic versions 5
  • References 6
  • External links 7

Indications (approved uses)

Experimental use

Mode of action

Hycamtin or topotecan is a semi-synthetic derivative of camptothecin. Camptothecin is a natural product extracted from the bark of the tree Camptotheca acuminata. Topoisomerase-I is a nuclear enzyme that relieves torsional strain in DNA by opening single strand breaks.[6] Once topoisomerase-I creates a single strand break, the DNA can rotate in front of the advancing replication fork. Topotecan intercalates between DNA bases. This intercalation disrupts the DNA duplication machinery when it reaches a site where topotecan is intercalated. This disruption prevents DNA replication, and ultimately leads to cell death. Mammalian cells cannot efficiently repair these double strand breaks.[7] This process leads to breaks in the DNA strand resulting in apoptosis.

Side effects

  • Myelosuppression
  • Diarrhea
  • Susceptibility to infection

Generic versions

Two generic versions have been approved in EU, and in Nov 2010 the US FDA approved a generic version.[8][9]


  1. ^
  2. ^
  3. ^ FDA
  4. ^
  5. ^ Press release
  6. ^ Pommier, Y., Leo, E., Zhang, H., Marchand, C. 2010. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 17: 421-433.
  7. ^ Staker, B.L. et al (2002). "The mechanism of topoisomerase I poisoning by a camptothecin analog". PNAS 99 (24): 15387–15392.  
  8. ^ "FDA Rubber-Stamps APP Pharma’s Generic Topotecan for Small Cell Lung and Cervical Cancers". 30 Nov 2010. 
  9. ^ DNA Topoisomerases and Cancer, Yves Pommier Editor, Humana Press 2012

External links

  • NCI Drug Dictionary Definition of Topotecan
  • NCI Drug Information for Patients
  • Use for ovarian cancer
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.